Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy

Shingo Hatakeyama; Naotaka Nishiyama; Taketo Kawai; Sho Sekito; Tomokazu Sazuka; Fumihiko Urabe; Keiji Yasue; Hiroshi Kitamura; Wataru Fukuokaya; Yoshiyuki Matsui; Shuichi Tatarano; Jun Miki; Katsuyoshi Hashine; Takeshi Sano; Kenichiro Shiga; Yusuke Sugino; Rikiya Taoka; Takuji Hayashi; Koichiro Wada; Junichi Inokuchi; Hiroaki Matsumoto; Soki Kashima; Makito Miyake; Kiyoaki Nishihara; Yuto Matsushita; Yoji Murakami; Ryoichi Saito; Hirohito Naito; Noriya Yamaguchi; Shotaro Nakanishi; Kei Daizumoto; Chikara Οhyama; Takashige Abe; Ayumu Matsuda; Minoru Kato; Takashi Kawahara; Masato Fujii; Motohiro Taguchi; Ryo Maruyama

doi:10.1002/cam4.70782

Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy

Shingo Hatakeyama(Hirosaki University), Naotaka Nishiyama(University of Toyama), Taketo Kawai(National Center for Global Health and Medicine), Sho Sekito(Aichi Cancer Center), Tomokazu Sazuka(Chiba University), Fumihiko Urabe(Jikei University School of Medicine), Keiji Yasue(Higashi Nagoya National Hospital), Hiroshi Kitamura(Tohoku University), Wataru Fukuokaya(Jikei University School of Medicine), Yoshiyuki Matsui(Tokyo National Hospital), Shuichi Tatarano(Kagoshima University), Jun Miki(Jikei University School of Medicine), Katsuyoshi Hashine(Shikoku Cancer Center), Takeshi Sano(Tokushima University), Kenichiro Shiga(Harasanshin Hospital), Yusuke Sugino(Mie University), Rikiya Taoka(Kagawa University), Takuji Hayashi(Osaka International Cancer Institute), Koichiro Wada(Shimane University), Junichi Inokuchi(Kyushu University), Hiroaki Matsumoto(Yamaguchi University), Soki Kashima(Akita University), Makito Miyake(Nara Medical University), Kiyoaki Nishihara(Kurume University), Yuto Matsushita(Hamamatsu University School of Medicine), Yoji Murakami(Kumamoto University), Ryoichi Saito(University of Miyazaki), Hirohito Naito(Kagawa University), Noriya Yamaguchi(Tottori University), Shotaro Nakanishi(University of the Ryukyus), Kei Daizumoto(Tokushima University), Chikara Οhyama(Hirosaki University), Takashige Abe(Hokkaido University), Ayumu Matsuda(Tokyo National Hospital), Minoru Kato(Osaka International Cancer Institute), Takashi Kawahara(University of Tsukuba), Masato Fujii(Niigata University), Motohiro Taguchi(Hyogo University), Ryo Maruyama(Niigata University)

Cancer Medicine

April 29, 2025

10.1002/cam4.70782

Cited by 8

Related Papers

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

|The Lancet Oncology|2017|1.8k

Extracellular vesicles as biomarkers and therapeutic targets for cancer

|American Journal of Physiology-Cell Physiology|2019|412

The Zinc Transporter SLC39A13/ZIP13 Is Required for Connective Tissue Development; Its Involvement in BMP/TGF-β Signaling Pathways

|PLoS ONE|2008|291

Circulating miRNA panels for specific and early detection in bladder cancer

|Cancer Science|2018|282

Autophagy regulates lipid metabolism through selective turnover of NCoR1

|Nature Communications|2019|200